期刊文献+

人白细胞介素7重组蛋白原核表达载体在大肠杆菌中的表达和鉴定 被引量:4

Expression and identification of recombinant human interleukin 7 product in Escherichia coli
在线阅读 下载PDF
导出
摘要 目的:构建重组人白细胞介素7(rhIL-7)的原核表达载体,在大肠杆菌中表达并鉴定。方法:以RT-PCR方法扩增编码IL-7的cDNA片段,插入至pET-3d载体中,构建rhIL-7的原核表达载体,阳性克隆经测序鉴定,转化至大肠杆菌BL21(DE3),优化rhIL-7表达条件,利用免疫印迹鉴定重组蛋白。结果:重组载体经DNA测序显示包含正确的rhIL-7编码序列,重组载体转入大肠杆菌后,经IPTG诱导后外源蛋白表达,相对分子质量为17 400,与IL-7理论分子质量一致;免疫印迹显示,外源蛋白可以被人IL-7特异性抗体识别,表明在原核表达的外源蛋白是rhIL-7。rhIL-7主要表达于包涵体中,包涵体表达优化条件为:温度为37℃、IPTG浓度为0.4 mmol/L、诱导时间为4h。结论:成功的构建了rhIL-7的原核表达载体。 Aim:To construct a prokaryotic expression vector for human interleukin7(IL-7),identify its expression product and optimize its expression condition. Methods: The cDNA fragment encoding human IL-7 was amplified by RT-PCR from the total RNA of human PBMC,and then the IL-7 gene was cloned into pET-3d plasmid to construct a prokaryotic expression vector.The positive clone was analyzed by DNA sequencing.The recombinant protein was expressed in Escherichia coli(E.coli) BL21(DE3) strain and identified with Western blotting.Results: The prokaryotic expression vector forIL-7 was constructed and confirmed by sequencing.The expression vector was transformed into E.coli and was expressed in after induction with IPTG.The relative molecular weight of the protein was 17 400,which is consistent with theoretical value.Western blotting showed that the recombinant protein was mainly presented in inclusion bodies.The optimized expression condition was 4 h induction at 37 ℃ with 0.4 mmol/L IPTG.Conclusion:The prokaryotic expression vector for human IL-7 has been constructed successfully and the expression condition has been optimized,which has paved the way for further study on human IL-7.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2010年第4期331-335,共5页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 国家自然科学基金项目(30572199 30371651)
关键词 白细胞介素7 原核表达载体 包涵体表达 免疫印迹 interleukin 7 prokaryotic expression inclusion body Western blotting
  • 相关文献

参考文献11

  • 1NAMEN A E,SCHMIERER A E,MARCH C J,et al.B-cell precursor growth-promoting activity.Purification and characterization of a growth factor active on lymphocyte precursors[J].J Exp Med,1988,167(3):988-1002.
  • 2WATSON J D,MORRISSEY P J,NAMEN A E,et al.Effect of IL-7 on the growth of fetal thymocytes in culture[J].J Immunol,1989,143(4):1215-1222.
  • 3ALDERSON M R,TOUGH T W,ZIEGLER S F,et al.Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes[J].J Exp Med,1991,173(4):923-930.
  • 4LU H,ZHAO Z,KALINA T,et al.Interleukin-7 improves reeonstitution of antiviral CD4 T cells[J].Clin Immunol,2005,114(1):30-41.
  • 5王慧,周佩军.白介素7及其受体的生理功能与免疫重建[J].肾脏病与透析肾移植杂志,2007,16(4):349-353. 被引量:4
  • 6PELLEGRINI M,CALZASCIA T,ELFORD A R,et al.Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies[J].Nat Med,2009,15(5):528-536.
  • 7何贤辉,徐丽慧,曾耀英,刘毅,蔡小嫦.HLA-A*0207重链胞外区原核表达载体的构建及表达[J].暨南大学学报(自然科学与医学版),2004,25(4):413-419. 被引量:2
  • 8FRY T J,MACKALL C L.Interleukin-7:from bench to clinic[J].Blood,2002,99(11):3892-3904.
  • 9ROSENBERG S A,SPORTES C,AHMADZADEH M,et al.IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells[J].J Immunother,2006,29(3):313-319.
  • 10SASSON S C,ZAUNDERS J J,ZANETTI G,et al.Increased plasma interleukin-7 leve1 correlates with decreased CD127 and Increased CD132 extraeellular expression on T cell subsets in patients with HIV-1 infection[J].J Infect Dis,2006,193(4):505-514.

二级参考文献33

  • 1GARBOCZI D N, HUNG D T, WILEY D C. HLA-A2-peptide complexes: Refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides [J]. Proc Natl Acad Sci USA, 1992, 89(8): 3429-3433.
  • 2BODINIER M, PEYRAT M A, TOURNAY C, et al. Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding [J]. Nat Med, 2000, 6(6):707-710.
  • 3HARTY J T, TVINNEREIM A R, WHITE D W. CD8+ T cell effector mechanisms in resistance to infection [J]. Annu Rev Immunol, 2000, 18: 275-308.
  • 4MEIDENBAUER N, HOFFMANN T K, DONNENBERGC A D. Direct visualization of antigen-specific T cells using peptide-MHC-class I tetrameric complexes [J]. Methods, 2003, 31(2):160-171.
  • 5APPAY V, ROWLAND-JONES S L. The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining [J]. J Immunol Methods, 2002, 268(1): 9-19.
  • 6ALTMAN J D, MOSS P AH, GOULDER P J R, et al. Phenotypic analysis of antigen-specific T lymphocytes[J]. [Published erratum appears in Science 1998, 280(5371):1821] Science, 1996, 274 (5284): 94-96.
  • 7BOUSSO P. Generation of MHC-peptide tetramers: a new opportunity for dissecting T-cell immune responses [J]. Microbes Infec, 2000, 2(4): 425-429.
  • 8LAEMMLI U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4 [J]. Nature, 1970, 227(259):680-685.
  • 9MARSH S G E,PARHAM P, BARBER L D. The HLA class I and class II loci [A]. In: MARSH S G E,PARHAM P, BARBER L D, eds. The HLA Facts Book[C]. London: Academic Press, 2000:100-150.
  • 10Seddiki N,Santner-Nanan B,Martinson J,et al.Expression of interleukin (IL)-2 and IL-7 receptors discriminates between regulatory and activated T cells.J Exp Med,2006,203(7):1693-1700.

共引文献4

同被引文献25

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部